Our findings demonstrate the crucial role of exosomal ADAM17 in the hematogenous metastasis of CRC and its potential function as a valuable blood-based biomarker and target for intervention strategies against CRC metastasis. Here, ADAM17 is linked to colorectal carcinoma.